Article Details
Retrieved on: 2022-10-03 18:02:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment of Rahul Singhvi, Sc.D ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here